FeesSafety
Pluang+

Greenwich LifeSciences' breast cancer immunotherapy advances with abstracts accepted at SABCS 2026.

Market News
17 Nov 2026, 13:00 WIB
GlobeNewsWire
View Source
Bullish
Greenwich LifeSciences' breast cancer immunotherapy advances with abstracts accepted at SABCS 2026.

Greenwich LifeSciences announced that two abstracts related to its Phase III clinical trial FLAMINGO-01, testing the immunotherapy GLSI-100 to prevent breast cancer recurrence, have been accepted for presentation at the San Antonio Breast Cancer Symposium (SABCS) 2026. The posters will be presented on December 9, highlighting ongoing clinical trial data. This recognition at a major global breast cancer conference underscores the potential of GLSI-100 as a treatment option. Investors and the public can access updated corporate and trial information on the company's website during the event.

Greenwich LifeSciences is noted here with a market context snapshot from Pluang's health sector data. For readers following health stocks, as of Nov 17, 2026 17:11 WIB, 48 of 150 priced US health-sector stocks rose while 85 fell. Notable movers include Ionis Pharmaceuticals Inc. (IONS) at USD 28.58 with a 1-day change of +2.03% and a typical hold time on Pluang of 6 days, Twist Bioscience Corp (TWST) at USD 103.05 with a 1-day change of -1.89% and 100% buy order activity, and Medline Inc. (MDLN) at USD 38.43 with a 1-day change of -1.89% and a typical hold time of 7 days.

More News

Microsoft expands use of Haivision tech for live production of 600+ global events annually

Microsoft expands use of Haivision tech for live production of 600+ global events annually

Microsoft has expanded its partnership with Haivision by adopting the Makito ONE video transport platform, Makito X4 video encoders and decoders, Haivision Pro mobile transmitters, and Haivision Hub 360 for live production of over 600 global events e...

Market News
Bullish
14 minutes ago
NVIDIA forms new committee to oversee national security and export control compliance.

NVIDIA forms new committee to oversee national security and export control compliance.

NVIDIA's Board of Directors has established the National Security and Export Control Oversight Committee to manage the company's national security policies and export control compliance. Chaired by Suzanne Nora Johnson, the committee will oversee NVI...

Market News
Neutral
1 hour ago
Malaysia's e-commerce market to nearly double to $25.65B by 2032, driven by mobile shopping and digital payments.

Malaysia's e-commerce market to nearly double to $25.65B by 2032, driven by mobile shopping and digital payments.

Malaysia's e-commerce market is projected to grow from $13.85 billion in 2027 to $25.65 billion by 2032, with a CAGR of 13.12%. Growth is fueled by increased smartphone use, digital wallet adoption, expanding logistics, and social commerce. B2C remai...

Market News
Bullish
1 hour ago
Burning Rock schedules 2026 AGM on Dec 22 to approve auditor and re-elect directors

Burning Rock schedules 2026 AGM on Dec 22 to approve auditor and re-elect directors

Burning Rock Biotech Limited announced its 2026 Annual General Meeting will be held on December 22, 2026, at its Shanghai office. The meeting will cover ratifying Ernst & Young Hua Ming LLP as auditor for 2026, re-electing directors Zhihong Zhang and...

Company Fundamentals
Neutral
1 hour ago
Bernstein SocGen downgrades PepsiCo to Underperform amid weak demand and rising costs

Bernstein SocGen downgrades PepsiCo to Underperform amid weak demand and rising costs

Bernstein SocGen Group downgraded PepsiCo's stock rating from Market Perform to Underperform due to weak North American demand, rising input costs, and margin pressures. PepsiCo's shares have fallen 2.4% over the past six months, underperforming its ...

Analyst Insights
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App